- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 354-368 of
1,170 results
2030 Exhibit: Petition for Inter Partes Review of US Patent No 9,669,069 B2, Apote...
Document
IPR2022-01524, No. 2030 Exhibit - Petition for Inter Partes Review of US Patent No 9,669,069 B2, Apotex Inc v Regeneron Pharms, Inc, IPR2022 00301 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2011 Exhibit: File History of US Patent Application 17112,404
Document
IPR2022-01524, No. 2011 Exhibit - File History of US Patent Application 17112,404 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2010 Exhibit: File History of US Patent Application 17072,417
Document
IPR2022-01524, No. 2010 Exhibit - File History of US Patent Application 17072,417 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2032 Exhibit: etition for Inter Partes Review of US Patent No 9,254,338 B2, Apotex...
Document
IPR2022-01524, No. 2032 Exhibit - etition for Inter Partes Review of US Patent No 9,254,338 B2, Apotex Inc v Regeneron Pharms, Inc, IPR2022 00298 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2001 Exhibit: Scheduling Order, Regeneron Pharms, Inc v Mylan Pharms Inc, Case...
Document
IPR2022-01524, No. 2001 Exhibit - Scheduling Order, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2028 Exhibit: Regeneron’s Opening Claim Construction Brief, Regeneron Pharms,...
Document
IPR2022-01524, No. 2028 Exhibit - Regeneron’s Opening Claim Construction Brief, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2004 Exhibit: Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 0088...
Document
IPR2022-01524, No. 2004 Exhibit - Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00880 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2008 Exhibit: File History of US Patent 10,857,205 Part 2 of 7
Document
IPR2022-01524, No. 2008-2 Exhibit - File History of US Patent 10,857,205 Part 2 of 7 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2008 Exhibit: File History of US Patent 10,857,205 Part 6 of 7
Document
IPR2022-01524, No. 2008-6 Exhibit - File History of US Patent 10,857,205 Part 6 of 7 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2014 Exhibit: Mylans Answer, Defenses, and Counterclaims to Plaintiff’s Complaint...
Document
IPR2022-01524, No. 2014 Exhibit - Mylans Answer, Defenses, and Counterclaims to Plaintiff’s Complaint, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec....
|
|
Cite Document
2022 Exhibit: Eylea aflibercept Injection label, revised May 2016
Document
IPR2022-01524, No. 2022 Exhibit - Eylea aflibercept Injection label, revised May 2016 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2031 Exhibit: Petition for Inter Partes Review of US Patent No 9,254,338 B2, Mylan...
Document
IPR2022-01524, No. 2031 Exhibit - Petition for Inter Partes Review of US Patent No 9,254,338 B2, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00881 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2019 Exhibit: Preliminary Response of Patent Owner Regeneron Pharmaceuticals,...
Document
IPR2022-01524, No. 2019 Exhibit - Preliminary Response of Patent Owner Regeneron Pharmaceuticals, Inc, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2022 01225 (P.T.A.B. Dec. 23, 202...
|
|
Cite Document
2024 Exhibit: CENTER FOR DRUG EVALUATION RESEARCH, Medical Review, BL...
Document
IPR2022-01524, No. 2024 Exhibit - CENTER FOR DRUG EVALUATION RESEARCH, Medical Review, BLA No 125156 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
2006 Exhibit: File History of US Patent 9,669,069
Document
IPR2022-01524, No. 2006 Exhibit - File History of US Patent 9,669,069 (P.T.A.B. Dec. 23, 2022)
|
|
Cite Document
